MedPath
NMPA Approval

Tirzepatide Injection

国药准字HJ20240021

July 23, 2024

Drug Information

替尔泊肽注射液

穆峰达

注射剂

按C₂₂₅H₃₄₈N₄₈O₆₈计,0.5ml∶7.5mg

化学药品

July 23, 2024

May 14, 2029

Company Information

Applicant Company

Papendorpseweg 83, 3528 BJ Utrecht, The Netherlands

Manufacturing Company

Lilly Corporate Center Indianapolis, Indiana 46285 USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

替尔泊肽注射液 - NMPA 批准文号 | MedPath